Singapore markets open in 41 minutes

Willow Biosciences Inc. (WLLW.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
0.1100-0.0050 (-4.35%)
At close: 02:52PM EDT
Currency in CAD

Valuation measures4

Market cap (intra-day) 14.63M
Enterprise value 13.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.19
Price/book (mrq)4.26
Enterprise value/revenue 11.62
Enterprise value/EBITDA -332.50

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-8.00%
S&P500 52-week change 323.33%
52-week high 30.1500
52-week low 30.0600
50-day moving average 30.0917
200-day moving average 30.0946

Share statistics

Avg vol (3-month) 367.86k
Avg vol (10-day) 3165.67k
Shares outstanding 5127.22M
Implied shares outstanding 6127.22M
Float 889.98M
% held by insiders 127.28%
% held by institutions 10.12%
Shares short (15 May 2024) 421.82k
Short ratio (15 May 2024) 40.45
Short % of float (15 May 2024) 4N/A
Short % of shares outstanding (15 May 2024) 40.02%
Shares short (prior month 15 Apr 2024) 412k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 327 Mar 2017
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,815.69%

Management effectiveness

Return on assets (ttm)-76.38%
Return on equity (ttm)-159.53%

Income statement

Revenue (ttm)949k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-81.40%
Gross profit (ttm)N/A
EBITDA -10.29M
Net income avi to common (ttm)-10.62M
Diluted EPS (ttm)-0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2M
Total cash per share (mrq)0.02
Total debt (mrq)2.03M
Total debt/equity (mrq)131.61%
Current ratio (mrq)1.42
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-8.85M
Levered free cash flow (ttm)-5.21M